Antiepileptic
Levetiracetam
Each mL of oral solution contains:
Levetiracetam 100 mg
Excipients q.s.
Bottle with 300 mL of oral solution
LEOVAL is indicated as monotherapy in the treatment of partial onset seizures, with or without secondary generalization in adults and adolescents over 16 years of age with a new diagnosis of epilepsy.
LEOVAL is indicated as concomitant therapy:
- In the treatment of partial onset seizures with or without secondary generalization in adults, adolescents and children over 4 years of age with epilepsy.
-In the treatment of myoclonic seizures in adults and adolescents over 12 years of age with Juvenile Myoclonic Epilepsy.
-In the treatment of primary generalized tonic-clonic seizures in adults and adolescents over 12 years of age with Generalized Idiopathic Epilepsy.